Skip to content

SARS-CoV-2 and COVID-19 Research

Most cited papers

  1. Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine · 2020 · 30,981 citations
  2. A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine · 2020 · 28,898 citations
  3. A pneumonia outbreak associated with a new coronavirus of probable bat originNature · 2020 · 22,306 citations
  4. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA · 2020 · 20,802 citations
  5. Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine · 2020 · 14,825 citations
  6. A new coronavirus associated with human respiratory disease in ChinaNature · 2020 · 11,925 citations
  7. Dexamethasone in Hospitalized Patients with Covid-19New England Journal of Medicine · 2020 · 11,744 citations
  8. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine · 2020 · 10,241 citations
  9. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1New England Journal of Medicine · 2020 · 10,233 citations
  10. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA · 2020 · 9,365 citations
  11. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience · 2020 · 8,791 citations
  12. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology · 2020 · 8,786 citations
  13. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine · 2020 · 8,396 citations
  14. WHO Declares COVID-19 a Pandemic.Acta bio-medica dell'Ateneo parmense/Acta biomedica · 2020 · 8,022 citations
  15. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance · 2020 · 7,448 citations
  16. Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine · 2020 · 7,417 citations
  17. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research · 2020 · 7,006 citations
  18. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)International Journal of Surgery · 2020 · 6,287 citations
  19. First Case of 2019 Novel Coronavirus in the United StatesNew England Journal of Medicine · 2020 · 6,146 citations
  20. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaNew England Journal of Medicine · 2012 · 5,809 citations
  21. Origin and evolution of pathogenic coronavirusesNature Reviews Microbiology · 2018 · 5,749 citations
  22. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology · 2004 · 5,745 citations
  23. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19New England Journal of Medicine · 2020 · 5,691 citations
  24. Characteristics of SARS-CoV-2 and COVID-19Nature Reviews Microbiology · 2020 · 5,559 citations
  25. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19New England Journal of Medicine · 2020 · 5,271 citations
  26. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2Science · 2020 · 5,036 citations
  27. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the statusMilitary Medical Research · 2020 · 4,944 citations
  28. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, ChinaClinical Infectious Diseases · 2020 · 4,889 citations
  29. Clinical and immunological features of severe and moderate coronavirus disease 2019Journal of Clinical Investigation · 2020 · 4,832 citations
  30. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA · 2020 · 4,826 citations
  31. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet · 2020 · 4,709 citations
  32. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeNew England Journal of Medicine · 2003 · 4,631 citations
  33. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS CoronavirusJournal of Virology · 2020 · 4,436 citations
  34. A Novel Coronavirus Associated with Severe Acute Respiratory SyndromeNew England Journal of Medicine · 2003 · 4,361 citations
  35. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases · 2020 · 4,341 citations
  36. Epidemiology of COVID-19 Among Children in ChinaPEDIATRICS · 2020 · 4,262 citations
  37. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell · 2020 · 4,250 citations
  38. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy · 2020 · 4,090 citations
  39. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance RatesVaccines · 2021 · 2,212 citations
  40. A global database of COVID-19 vaccinationsNature Human Behaviour · 2021 · 2,111 citations
  41. Vaccine hesitancy: the next challenge in the fight against COVID-19European Journal of Epidemiology · 2020 · 1,765 citations
  42. Determinants of COVID-19 vaccine acceptance in the USEClinicalMedicine · 2020 · 1,577 citations

Metadata from OpenAlex (CC0).